Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rang in Aktien #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Aktienkurs
$0.00060315
Zuletzt synchronisiert: 2024-09-27
Marktkapitalisierung
$1.65M
Veränderung (1 Tag)
19.64%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Amniotics AB (publ) (AMNI)

Kategorie

Aktien-Split-Historie für Amniotics AB (publ) (AMNI)
Die Aktie Amniotics AB (publ) (Symbol: AMNI) durchlief insgesamt 2 Aktiensplits.
Der letzte Aktiensplit fand am Oct 06, 2023 statt.
Eine AMNI-Aktie, die vor dem Feb 20, 2023 gekauft wurde, entspricht heute 10.25586 AMNI-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2023-10-06 681:200 x3.405 x10.25586
2023-02-20 753:250 x3.012 x3.012
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE